Shanghai Bio-heart Biological Technology Co Ltd - Class H

HKSE:02185 (China)   Class H
HK$ 1.68 (0%) Dec 3
At Loss
P/B:
0.53
Market Cap:
HK$ 421.90M ($ 54.21M)
Enterprise V:
HK$ 129.73M ($ 16.67M)
Volume:
100.00
Avg Vol (2M):
72.94K
Trade In:
Volume:
100.00
At Loss
Avg Vol (2M):
72.94K

Business Description

Description
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension.
Name Current Vs Industry Vs History
Cash-To-Debt 275.08
Equity-to-Asset 0.92
Debt-to-EBITDA -0.01
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 59.95
9-Day RSI 47.56
14-Day RSI 45.7
6-1 Month Momentum % -10.05
12-1 Month Momentum % -53.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 24.62
Quick Ratio 24.39
Cash Ratio 18.8

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.8
Shareholder Yield % 3.81
Name Current Vs Industry Vs History
ROE % -15.11
ROA % -13.81
ROIC % -19.03
ROC (Joel Greenblatt) % -122.58
ROCE % -14.92

Financials

HKSE:02185's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Shanghai Bio-heart Biological Technology Co Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$)
EPS (TTM) (HK$) -0.523
Beta 0
Volatility % 39.19
14-Day RSI 45.7
14-Day ATR (HK$) 0.083745
20-Day SMA (HK$) 1.752
12-1 Month Momentum % -53.23
52-Week Range (HK$) 1.26 - 4.27
Shares Outstanding (Mil) 243.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Shanghai Bio-heart Biological Technology Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Shanghai Bio-heart Biological Technology Co Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Shanghai Bio-heart Biological Technology Co Ltd Frequently Asked Questions

What is Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185)'s stock price today?
The current price of HKSE:02185 is HK$1.68. The 52 week high of HKSE:02185 is HK$4.27 and 52 week low is HK$1.26.
When is next earnings date of Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185)?
The next earnings date of Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185) is .
Does Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185) pay dividends? If so, how much?
Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185) does not pay dividend.

Press Release

Subject Date
No Press Release